Inventor · disambiguated record
Marco Gymnopoulos
Also filed as: GYMNOPOULOS MARCO
4 granted patents·6 pending applications·4 citations·filing 2010–2024
62Inventor score
Top patents by PatentIndex Score
10 records- 0175US11299547B2CMET monoclonal binding agents, drug conjugates thereof and uses thereofMITSUBISHI TANABE PHARMA CORP·Filed 2017·Granted Apr 12, 2022·2 cites·20 claims
- 0275US10800856B2Prostate-specific membrane antigen antibody drug conjugatesAMBRX INC·Filed 2013·Granted Oct 13, 2020·2 cites·5 claims
- 0371US2025032632A1DRUG CONJUGATES OF cMET MONOCLONAL BINDING AGENTS, AND USES THEREOFMITSUBISHI TANABE PHARMA CORP·Filed 2024·Application pending·0 cites
- 0466US2024239889A1Anti-cd3-folate conjugates and their usesAMBRX INC·Filed 2023·Application pending·0 cites
- 0558US12060427B2Drug conjugates of cMET monoclonal binding agents, and uses thereofMITSUBISHI TANABE PHARMA CORP·Filed 2019·Granted Aug 13, 2024·0 cites·16 claims
- 0658US2022033518A1Prostate-specific membrane antigen antibody drug conjugatesAMBRX INC·Filed 2020·Application pending·0 cites
- 0749US11851488B2Anti-CD3-folate conjugates and their usesAMBRX INC·Filed 2016·Granted Dec 26, 2023·0 cites·23 claims
- 0845US2022249679A1Bi-specific binding agents targeting syndecan-1 and fibroblast growth factor receptorMITSUBISHI TANABE PHARMA CORP·Filed 2019·Application pending·0 cites
- 0943US2015152187A1Anti-PSMA Antibodies Conjugated to Nuclear Receptor Ligand PolypeptidesAMBRX INC·Filed 2013·Application pending·0 cites
- 1034US2011195111A1Aqueous compositions and methodsNATIVIS INC·Filed 2010·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Marco Gymnopoulos files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →